Why weight loss drugs cost much more for Americans

The latest stories trending on MedCity News.

Editor's Pick

Top Story Report: Weight Loss Drugs Cost Significantly More for Americans than Peer Countries A new KFF analysis compared list prices for Ozempic, Wegovy, Rybelsus and Mounjaro. It found that the U.S. has much higher list prices for these drugs than other peer countries while also having the highest rate of obesity. Sponsored Content Driving for Results: 3 Key Benefits of Telehealth Presented by Greenway Health Explore the myriad benefits telehealth offers to healthcare providers and patients alike. From enhanced convenience and improved privacy to streamlined workflows and elevated patient satisfaction, find out how telehealth is reshaping the future of healthcare delivery. Learn More>> Tick Tock Your opportunity to save $150 is ticking away. If you don't purchase your ticket now, not only will you lose out on saving some money, but you could lose out on valuable industry knowledge, innovative ideas, partners and connections. All that and more awaits you at INVEST Digital Health on October 26th in Dallas at Pegasus Park. Get My Ticket Now

Featured News

Here's Why Many Americans Are Unable to Afford Their Drugs Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it to market nor its therapeutic value. Corporate Head of Benefits – The Most Powerful Position in Healthcare for 60% of Americans Employer-sponsored health insurance now costs approximately $12,000 per plan member per year. Accordingly, for many employers, healthcare and health insurance are the second largest company expense after payroll. The Head of Benefits is in charge of this expense and is in the best position to use it for positive change. Why OneOncology Is Adopting Verily's Clinical Trial Management System OneOncology recently announced that it is deploying Verily's clinical trial management platform across 11 of its community oncology clinics. Adopting Verily's software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company's chief medical officer said.

Resources

AI in Healthcare: Scratching the Surface Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe